Document is current
Any future updates will be listed below
-
Authors
Kameneva, Polina
Artemov, Artem V.
Kastriti, Maria Eleni http://orcid.org/0000-0002-0563-7399
Faure, Louis http://orcid.org/0000-0003-4621-586X
Olsen, Thale K.
Otte, Jörg
Erickson, Alek
Semsch, Bettina
Andersson, Emma R. http://orcid.org/0000-0002-8608-625X
Ratz, Michael
Frisén, Jonas
Tischler, Arthur S.
de Krijger, Ronald R.
Bouderlique, Thibault http://orcid.org/0000-0002-3926-990X
Akkuratova, Natalia
Vorontsova, Maria
Gusev, Oleg
Fried, Kaj
Sundström, Erik
Mei, Shenglin
Kogner, Per http://orcid.org/0000-0002-2202-9694
Baryawno, Ninib
Kharchenko, Peter V. http://orcid.org/0000-0002-6036-5875
Adameyko, Igor http://orcid.org/0000-0001-5471-0356
-
Funding
Funding for this research was provided by:
Knut och Alice Wallenbergs Stiftelse
Vetenskapsrådet
European Molecular Biology Organization
Russian Science Foundation (19-15-00241, 16-15-10273, N19-14-00260)
Austrian Science Fund (DOC 33-B27)
Novo Nordisk Fonden
- License Information
-
More Information
Article History
Received: 30 March 2020
Accepted: 16 February 2021
First Online: 8 April 2021
Competing interests
: P.V.K. serves on scientific advisory boards for Celsius Therapeutics Inc. and Biomage Inc. The other authors declare no conflict of interests.
